Literature DB >> 24189282

The role of PTPN22 in autoimmunity: learning from mice.

Junfeng Zheng1, Frank Petersen2, Xinhua Yu3.   

Abstract

Protein tyrosine phosphatase nonreceptor 22 (PTPN22) represents a strong susceptibility gene which is shared by many autoimmune diseases. Exploring the mechanism behind this association could help to understand their pathogenesis as well as to identify novel therapeutical targets. Recently, multiple mouse models including knock-out, knock-in, knock-down and transgenic mice were generated to delineate PTPN22s function in this context. Depending on the genetic background, mouse PTPN22_619W mutation results in spontaneous autoimmunity, essentially replicating the risk effect of the PTPN22_620W in human autoimmune diseases. Furthermore, findings from mouse models shed new light on both cellular as well as molecular mechanisms of the effect of PTPN22 on adaptive and innate immunity. Here we review recently emerged evidence of the interconnection between mouse PTPN22 and autoimmunity. We also discuss the consistence and discrepancy between findings derived from human and mouse studies.
© 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Autoimmune diseases; Autoimmunity; CSK; DC; Dendritic cell; GC; Germinal centers; IRF3; Interferon regulatory factor 3; LYP; Lymphoid tyrosine phosphatase; PEP; PEST domain-enriched tyrosine; PTPN22; Protein tyrosine phosphatase nonreceptor 22; RA; Regulatory T cells; Rheumatoid arthritis; SLE; Susceptibility gene; Systemic lupus erythematosus; T cell receptor; T1D; TCR; TLR; TNF receptor-associated factor 3; TRAF3; Toll like receptors; Treg; Type 1 diabetes; c-Src tyrosine; type 1 IFN; type 1 interferons

Mesh:

Substances:

Year:  2013        PMID: 24189282     DOI: 10.1016/j.autrev.2013.10.011

Source DB:  PubMed          Journal:  Autoimmun Rev        ISSN: 1568-9972            Impact factor:   9.754


  17 in total

Review 1.  The critical role of toll-like receptors--From microbial recognition to autoimmunity: A comprehensive review.

Authors:  Maximiliano Javier Jiménez-Dalmaroni; M Eric Gerswhin; Iannis E Adamopoulos
Journal:  Autoimmun Rev       Date:  2015-08-20       Impact factor: 9.754

Review 2.  The Contribution of PTPN22 to Rheumatic Disease.

Authors:  Tomas Mustelin; Nunzio Bottini; Stephanie M Stanford
Journal:  Arthritis Rheumatol       Date:  2019-03-02       Impact factor: 10.995

Review 3.  Human Leukocyte Antigen-Disease Associations in Rheumatoid Arthritis.

Authors:  Vincent van Drongelen; Joseph Holoshitz
Journal:  Rheum Dis Clin North Am       Date:  2017-08       Impact factor: 2.670

Review 4.  Molecular mechanisms in autoimmune type 1 diabetes: a critical review.

Authors:  Zhiguo Xie; Christopher Chang; Zhiguang Zhou
Journal:  Clin Rev Allergy Immunol       Date:  2014-10       Impact factor: 8.667

Review 5.  The role for protein tyrosine phosphatase non-receptor type 22 in regulating intestinal homeostasis.

Authors:  Marianne R Spalinger; Michael Scharl
Journal:  United European Gastroenterol J       Date:  2015-08-06       Impact factor: 4.623

6.  Potential role of PTPN22 in ankylosing spondylitis, comment on: associations of the PTPN22 and CTLA-4 genetic polymorphisms with Taiwanese ankylosing spondylitis.

Authors:  Shan-Shan Liu; Ye Ding; Ji-Quan Lou
Journal:  Rheumatol Int       Date:  2014-04-13       Impact factor: 2.631

7.  Experimental colitis in IL-10-deficient mice ameliorates in the absence of PTPN22.

Authors:  T Jofra; G Galvani; I Cosorich; L De Giorgi; A Annoni; A Vecchione; C Sorini; M Falcone; G Fousteri
Journal:  Clin Exp Immunol       Date:  2019-07-10       Impact factor: 4.330

Review 8.  Oxidative stress as a potential causal factor for autoimmune hemolytic anemia and systemic lupus erythematosus.

Authors:  Junichi Fujii; Toshihiro Kurahashi; Tasuku Konno; Takujiro Homma; Yoshihito Iuchi
Journal:  World J Nephrol       Date:  2015-05-06

9.  The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.

Authors:  J F Mendoza Rincón; D López Cano; S Jiménez Morales; M L Rivas Jiménez; R E Barbosa Cobos; J Ramírez Bello
Journal:  Clin Rheumatol       Date:  2016-03-07       Impact factor: 2.980

Review 10.  Autoimmunity in 2014.

Authors:  Carlo Selmi
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.